- Novo Nordisk falls on 2025 results, dragging Lilly (NVO:NYSE) Seeking Alpha
- Novo Nordisk shares tumble after company warns of sales hit this year CNBC
- Novo Says Sales Will Drop as US Pushes for Lower Drug Prices Bloomberg
- Novo Nordisk lowers sales, profits forecast as Wegovy faces growing competition statnews.com
- Novo Nordisk’s 2026 outlook in focus as competition pressures sales (NVO:NYSE) Seeking Alpha
